Bioinformatics approach to mRNA markers discovery for detection of circulating tumor cells in patients with gastrointestinal cancer

Cancer Detection and Prevention

Volumn 32, Issue 3, 2008, Pages 236-250

  Valladares Ayerbes, Manuel ^a   Díaz Prado, Silvia ^b   Reboredo, Marga ^a   Medina, Vanessa ^a   Iglesias Díaz, Pilar ^a   Lorenzo Patiño, Maria J ^a   Campelo, Rosario G ^a   Haz, Mar ^a   Santamarina, Isabel ^a   Antón Aparicio, Luis M ^a  

^a University Hospital Juan Canalejo   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Anterior gradient 2 homolog (Xenopus laevis) protein; Biological tumor markers; Databases nucleic acid; Epithelial cells; Gene expression pattern analysis; Metastasis; Neoplasm circulating cells; Plakophilin 3; Reverse transcriptase polymerase chain reaction; Tumor cell lines

Indexed keywords

CALCYCLIN; CLAUDIN 3; GALECTIN 4; MESSENGER RNA; ONCOPROTEIN; PLAKOPHILIN; PLAKOPHILIN 3; PROTEIN ANTERIOR GRADIENT 2; PROTEIN S 100; PROTEIN S100A16; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; BIOINFORMATICS; BONE MARROW; CANCER DIAGNOSIS; CANCER TISSUE; CLINICAL ARTICLE; COLON CANCER; COMPUTER MODEL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DNA LIBRARY; EXPRESSED SEQUENCE TAG; GENE AMPLIFICATION; GENE CONTROL; GENE IDENTIFICATION; GENETIC ANALYSIS; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; VALIDATION STUDY;

COMPUTATIONAL BIOLOGY; GASTROINTESTINAL NEOPLASMS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASTIC CELLS, CIRCULATING; PLAKOPHILINS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 52949099120     PISSN: 0361090X     EISSN: 15251500     Source Type: Journal    
DOI: 10.1016/j.cdp.2008.08.002     Document Type: Article

References (41)

1. Coleman M.P., Gatta G., Verdecchia A., Esteve J., Sant M., Storm H., et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14 5 Suppl. (2003) v128-v149
2. Vlems F.A., Diepstra J.H.S., Cornelissen I.M.H.A., Ruers T.J., Ligtenberg M.J., Punt C.J., et al. Limitations of cytokeratin 20 RT-PCR to detect disseminated tumour cells in blood and bone marrow of patients with colorectal cancer: expression in controls and downregulation in tumour tissue. Mol Pathol 55 (2002) 156-163
3. Dandachi N., Balic M., Stanzer S., Halm M., Resel M., Hinterleitner T.A., et al. Critical evaluation of real-time reverse transcriptase-polymerase chain reaction for the quantitative detection of cytokeratin 20 mRNA in colorectal cancer patients. J Mol Diagn 7 (2005) 631-637
4. Schuster R., Max N., Mann B., Heufelder K., Thilo F., Gröne J., et al. Quantitative real-time RT-PCR for detection of disseminated tumor cells in peripheral blood of patients with colorectal cancer using different mRNA markers. Int J Cancer 108 (2004) 219-227
5. Bustin S.A., and Mueller R. Real-time reverse transcription PCR (qRT-PCR) and its potential use in clinical diagnosis. Clin Sci (Lond) 109 (2005) 365-379
6. Salomon D.S., Brandt R., Ciardiello F., and Normanno N. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19 (1995) 183-232
7. Pantel K., and Alix-Panabieres C. The clinical significance of circulating tumor cells. Nat Clin Pract Oncol 4 (2007) 62-63
8. Sugita Y., Fujiwara Y., Hoon D.S., Miyamoto A., Sakon M., Kuo C.T., et al. Overexpression of beta 1,4-N-acetylgalactosaminyl-transferase mRNA as a molecular marker for various types of cancers. Oncology 62 (2002) 149-156
9. Murata K., Miyoshi E., Kameyama M., Ishikawa O., Kabuto T., Sasaki Y., et al. Expression of N-acetylglucosaminyl transferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin Cancer Res 6 (2000) 1772-1777
10. Pepe M.S., Etzioni R., Feng Z., Potter J.D., Thompson M.L., Thornquist M., et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93 (2001) 1054-1061
11. UniGene [database on the Internet]. Bethesda: National Library of Medicine (US); [cited Jan 22, 2006]. Digital Differential Display (DDD). Homo sapiens. Available from http://www.ncbi.nlm.nih.gov/UniGene/ddd.cgi?ORG=Hs.
12. Cancer Genome Anatomy Project [database on the Internet]. Bethesda (MD): National Cancer Institute (US); [cited December 15, 2005]. GeneFinder. Available from http://cgap.nci.nih.gov/Genes/GeneFinder.
13. Lal A., Lash A.E., Altschul S.F., Vekulescu V., Zhang L., McLendon R.E., et al. A public database for gene expression in human cancers. Cancer Res 59 (1999) 5403-5407
14. Cancer Genome Anatomy Project [database on the Internet]. Bethesda (MD): National Cancer Institute (US); [cited December 15, 2005]. Tissues. Virtual Northern. EGFR. Available from http://cgap.nci.nih.gov/Tissues/VirtualNorthern?TEXT=0&ORG=Hs&CID=488293.
15. Cancer Genome Anatomy Project [database on the Internet]. Bethesda (MD): National Cancer Institute (US); [cited December 15, 2005]. Tissues. Virtual Northern. MGAT5. Available from http://cgap.nci.nih.gov/Tissues/VirtualNorthern?TEXT=0&ORG=Hs&CID=651869.
16. Cancer Genome Anatomy Project [database on the Internet]. Bethesda (MD): National Cancer Institute (US); [cited December 15, 2005]. GoBrowser. Available from http://cgap.nci.nih.gov/Genes/GOBrowser.
17. Valladares Ayerbes M., Calvo L., Alonso G., Iglesias P., Lorenzo M.J., Brandón I., et al. Evaluation of messenger RNA of pituitary tumour-transforming gene-1 (PTTG1) as a molecular marker for micrometastasis. In: Li J.J., Li S.A., and Llombart-Bosch A. (Eds). Hormonal carcinogenesis IV (2005), Springer-Verlag, New York 462-468
18. Roche Applied Science [database on the Internet] [cited December 20, 2005]. Assay Design Center/ProbeFinder. Homo sapiens (Human). Available from http://www.universalprobelibrary.com.
19. Roche Applied Science [database on the Internet] [cited December 20, 2005]. Universal ProbeLibrary. Universal ProbeLibrary interest site. Assay Design Center/ProbeFinder. Homo sapiens (Human). Available from http://www.roche-applied-science.com.
20. -ΔΔCt method. Methods 25 (2001) 402-408
21. Vogel I., and Kalthoff H. Clinical relevance of tumor cell dissemination in colorectal, gastric and pancreatic carcinoma. In: Pantel K. (Ed). Micrometastasis (2003), Kluwer Academic Publishers, Dordrecht 139-172
22. Gupta G.P., and Massague J. Cancer metastasis: building a framework. Cell 127 (2006) 679-695
23. Smirnov D.A., Zweitzig D.R., Foulk B.W., Miller M.C., Doyle C.V., Piente K.J., et al. Global gene expression profiling of circulating tumor cells. Cancer Res 65 (2005) 4993-4997
24. Solmi R., Ugolini G., Rosati G., Zanotti S., Lauriola M., Montroni I., et al. Microarray-based identification and RT-PCR test screening for epithelial-specific mRNAs in peripheral blood of patients with colon cancer. BMC Cancer 6 (2006) 250
25. Solmi R., De Sanctis P., Zucchini C., Ugolini G., Rosati G., del Governatore M., et al. Search for epithelial-specific mRNAs in peripheral blood of patients with colon cancer by RT-PCR. Int J Oncol 25 (2004) 1049-1056
26. Bonne S., van Hengel J., Nollet F., Kools P., and van Roy F. Plakophilin-3, a novel armadillo-like protein present in nuclei and desmosomes of epithelial cells. J Cell Sci 112 (1999) 2265-2276
27. Schmidt A., Langbein L., Prätzel S., Rode M., Rackwitz H.R., and Franke W.W. Plakophilin 3-a novel cell-type-specific desmosomal plaque protein. Differentiation 64 (1999) 291-306
28. Bonné S., Gilbert B., Hatzfeld M., Chen X., Green K.J., and Van Roy F. Defining desmosomal plakophilin-3 interactions. J Cell Biol 161 (2003) 403-416
29. Brembeck F.H., Rosario M., and Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16 (2006) 51-59
30. Papagerakis S., Shabana A.H., Depondt J., Gehanno P., and Forest N. Immunohistochemical localization of plakophilins (PKP1, PKP2, PKP3, and p0071) in primary oropharyngeal tumors: correlation with clinical parameters. Hum Pathol 34 (2003) 565-572
31. Furukawa C., Daigo Y., Takano A., Ishikawa N., Kato T., Hayama S., et al. Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res 65 (2005) 7102-7110
32. Schwarz J., Ayim A., Schmidt A., Jäger S., Koch S., Baumann R., et al. Differential expression of desmosomal plakophilins in various types of carcinomas: correlation with cell type and differentiation. Hum Pathol 37 (2006) 613-622
33. Valladares-Ayerbes M, Díaz S, Medina V, Iglesias P, Lorenzo MJ, Santamarina I, et al. Evaluation of plakophilin 3 as a molecular marker for micrometastasis in gastrointestinal cancer. In: Grunbag SM, editor. Proceedings of the gastrointestinal cancer symposium; January 19-21, 2007; Orlando, USA. American Society of Clinical Oncology; 2007. p. 302 [Abstract 438].
34. Aigner K., Descovich L., Mikula M., Sultan A., Schreiber M., Mikulits W., et al. The transcription factor ZEB1 (dEF1) represses plakophilin 3 during human cancer progression. FEBS Letters 581 (2007) 1617-1624
35. Woelfle U., Cloos J., Sauter G., Riethdorf L., Janicke F., Van Diest P., et al. Molecular signature associated with bone marrow micrometastasis in human breast cancer. Cancer Res 63 (2003) 5679-5684
36. Zhang J.-S., Gong A., Cheville J.C., Smith D.I., and Young C.Y.F. AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer. Genes Chromosomes Cancer 43 (2005) 249-259
37. Fritzsche F.R., Dahl E., Pahl S., Burkhardt M., Luo J., Mayordomo E., et al. Prognostic relevance of AGR2 expression in breast cancer. Clin Cancer Res 12 (2006) 1728-1734
38. Lee S., Bang S., Song K., and Lee I. Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon. Oncol Rep 16 (2006) 747-754
39. Hong Zhu H., Lam D.C., Han K.C., Tin V.P., Suen W.S., Wang E., et al. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines. Cancer Lett 245 (2007) 303-314
40. Pohler E., Craig A.L., Cotton J., Lawrie L., Dillon J.F., Ross P., et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage. Mol Cell Proteomics 3 (2004) 534-547
41. Liu D., Rudland P.S., Sibson D.R., Platt-Higgins A., and Barraclough R. Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas. Cancer Res 65 (2005) 3796-3805